Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



An Investigational Immuno-therapy Study of Nivolumab or Placebo in Patients With Resected Esophageal or Gastroesophageal Junction Cancer

Multiple Cancer Types

The purpose of this study is to determine whether Nivolumab will improve overall survival, disease-free survival, or both compared with placebo.
Esophageal, Gastric/Gastroesophageal
III
Goff, Laura
NCT02743494
VICCGI1655

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: